Objectives: To investigate the clinical effectiveness and safety of fingolimod in the western
Iranian population. Methods: This study was performed as a prospective observational study …

… Anti-SSA antibody was positive in 96.97% (n = 96) of 99 patients with reported test results.
Based on the data available in these articles (n = 68 SS patients), SS was presented after …

Background COVID-19 is increasingly expanding all over the world. People who have an
underlying disease or taking immunosuppressive drugs are generally more likely to be …

Introduction There are increasing reports of COVID-19 related neurological complications
which may be due to direct viral invasion, or immune mediated inflammatory diseases such as …

Background The prevalence of COVID-19 is different in studies conducted in different
countries. The aim of this systematic review and meta-analysis is to estimate the pooled …

NMOSD is a disease shown to be highly associated with other diseases such as autoimmune
diseases. There are a few reports of this association with cancer. So, this systematic …

Background Neuromyelitys optica spectrum disorder (NMOSD) is a rare demyelinating disease;
as a result, the epidemiological data on this disorder is scarce. In this regard, the aim of …

Background : In recent years Artificial intelligence (AI) techniques are rapidly evolving into
clinical practices such as diagnosis and prognosis processes, assess treatment effectiveness, …

Background A large number of multiple sclerosis [MS] patients suffer from cognitive
dysfunction affecting their routine life in family and society. Investigating modifiable factors for …

Invasion of auto-reactive CD4+ T cells especially Th17 into central nervous system (CNS) is
an underlying pathogenic mechanism in multiple sclerosis (MS). CD4+ T cells release …